ANNOTATIONS.
出版信息
Br Med J. 1955 Dec 3;2(4952):1376-8.
Abstract
摘要
相似文献
1
ANNOTATIONS.注释
Br Med J. 1955 Dec 3;2(4952):1376-8.
2
Evaluating Computational Gene Ontology Annotations.评估计算基因本体注释
Methods Mol Biol. 2017;1446:97-109. doi: 10.1007/978-1-4939-3743-1_8.
3
Ontology-Based Prediction and Prioritization of Gene Functional Annotations.基于本体的基因功能注释预测与优先级排序
IEEE/ACM Trans Comput Biol Bioinform. 2016 Mar-Apr;13(2):248-60. doi: 10.1109/TCBB.2015.2459694.
4
GOAnnotator: linking protein GO annotations to evidence text.基因本体注释工具：将蛋白质的基因本体注释与证据文本相链接。
J Biomed Discov Collab. 2006 Dec 20;1:19. doi: 10.1186/1747-5333-1-19.
5
Embracing imperfect datasets: A review of deep learning solutions for medical image segmentation.拥抱不完美数据集：医学图像分割深度学习解决方案综述。
Med Image Anal. 2020 Jul;63:101693. doi: 10.1016/j.media.2020.101693. Epub 2020 Apr 3.
6
Learning in Virtual Reality: Bridging the Motivation Gap by Adding Annotations.虚拟现实中的学习：通过添加注释弥合动机差距。
Front Psychol. 2021 Mar 24;12:645032. doi: 10.3389/fpsyg.2021.645032. eCollection 2021.
7
NoisyGOA: Noisy GO annotations prediction using taxonomic and semantic similarity.NoisyGOA：利用分类学和语义相似性预测有噪声的基因本体注释
Comput Biol Chem. 2016 Dec;65:203-211. doi: 10.1016/j.compbiolchem.2016.09.005. Epub 2016 Sep 13.
8
AgBase: a unified resource for functional analysis in agriculture.AgBase：农业功能分析的统一资源。
Nucleic Acids Res. 2007 Jan;35(Database issue):D599-603. doi: 10.1093/nar/gkl936. Epub 2006 Nov 29.
9
NoGOA: predicting noisy GO annotations using evidences and sparse representation.NoGOA：利用证据和稀疏表示预测有噪声的基因本体注释
BMC Bioinformatics. 2017 Jul 21;18(1):350. doi: 10.1186/s12859-017-1764-z.
10
Incorporating Functional Annotations for Fine-Mapping Causal Variants in a Bayesian Framework Using Summary Statistics.在贝叶斯框架中使用汇总统计信息纳入功能注释以进行因果变异的精细定位。
Genetics. 2016 Nov;204(3):933-958. doi: 10.1534/genetics.116.188953. Epub 2016 Sep 21.
本文引用的文献
1
Treatment of hypertension; hypotensive drugs and mental changes.高血压的治疗；降压药与精神变化
Lancet. 1955 Jul 16;269(6881):116-7. doi: 10.1016/s0140-6736(55)92117-6.
2
Comparison of rescinnamine and reserpine as hypotensive agents.利血胺与利血平作为降压药的比较。
Lancet. 1955 Jul 16;269(6881):115-6. doi: 10.1016/s0140-6736(55)92116-4.
3
Pulmonary oedema due to salicylates, with report of a case.
Br J Radiol. 1955 Jun;28(330):314-6. doi: 10.1259/0007-1285-28-330-314.
4
Psychosis apparently produced by reserpine.明显由利血平引起的精神病。
J Am Med Assoc. 1955 Oct 29;159(9):839-40. doi: 10.1001/jama.1955.02960260009003.
5
Depression and anxiety occurring during Rauwolfia therapy.
J Am Med Assoc. 1955 Oct 29;159(9):836-9. doi: 10.1001/jama.1955.02960260006002.
6
Use of reserpine and Rauwolfia in psychoneuroses.利血平和萝芙木在精神神经症中的应用。
Br Med J. 1955 Nov 5;2(4948):1121-2. doi: 10.1136/bmj.2.4948.1121.
7
Rauwolfia serpentina (serpasil) in psychiatry.萝芙木（利血平）在精神病学中的应用。
J Neurol Neurosurg Psychiatry. 1955 Aug;18(3):225-7. doi: 10.1136/jnnp.18.3.225.
8
Pulmonary oedema complicating the treatment of rheumatic carditis with sodium salicylate.肺水肿使水杨酸钠治疗风湿性心脏炎的过程复杂化。
Arch Middx Hosp. 1955 Jul;5(3):172-6.
9
Mental depression in hypertensive patients treated for long periods with large doses of reserpine.长期大剂量使用利血平治疗的高血压患者出现精神抑郁。
N Engl J Med. 1954 Dec 16;251(25):1006-8. doi: 10.1056/NEJM195412162512504.
10
Clinical usage of Rauwolfia alkaloids, including reserpine (serpasil).萝芙木生物碱的临床应用，包括利血平（蛇根碱）。
Ann N Y Acad Sci. 1954 Apr 30;59(1):36-44. doi: 10.1111/j.1749-6632.1954.tb45916.x.
Zotero 插件